Despite fierce opposition from several areas, foundation hospitals look set to become a reality in 2004. But what will they …
Teva has agreed to acquire US generics company Sicor for $3.4 billion and increased its third quarter profits 63%, led …
Two Eli Lilly manufacturing sites have passed FDA inspections resolving a long-running dispute and paving the way for the launch …
Switching is not a given and a successful POM to P transition requires considerable research and planning to extend unique …
The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …
Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS …
A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …
New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.The Government hopes the best …
GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.The …
More than a quarter of hospital consultants are ready to resign or retire from the NHS if they dont receive …
GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with …
All NHS trusts will have to review how they report waiting times after a spot check found widespread distortion and …
Bayer and GlaxoSmithKline's new erectile dysfunction treatment Levitra has been launched in the UK, its first market after receiving European …
A chronic shortage of staff in some parts of the NHS is holding back improvements to the service, according to …